Title:
新規ピペラジノ-ジヒドロチエノピリミジン誘導体
Document Type and Number:
Japanese Patent JP5563466
Kind Code:
B2
Abstract:
A method for treating diseases associated with the inhibition of phosphodiesterase 4 (PDE4) enzyme in a patient comprising administering to the patient in need thereof a therapeutically effective amount of a dihydrothienopyrimidinesulphoxide of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof
Inventors:
Pouse Pascal
Henke Krishtov
Nicolaus Peter
Gegel Rolf
Fox thomas
Figen Dennis
Clinder Claus
Henke Krishtov
Nicolaus Peter
Gegel Rolf
Fox thomas
Figen Dennis
Clinder Claus
Application Number:
JP2010529385A
Publication Date:
July 30, 2014
Filing Date:
October 16, 2008
Export Citation:
Assignee:
Boehringer Ingelheim International GmbH
International Classes:
C07D495/04; A61K31/519; A61K31/5377; A61K31/55; A61K45/00; A61P1/00; A61P1/04; A61P9/10; A61P11/00; A61P11/06; A61P17/00; A61P19/02; A61P25/00; A61P25/04; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P27/02; A61P29/00; A61P35/00; A61P43/00; C07D519/00
Domestic Patent References:
| JP2005503345A |
Foreign References:
| WO2006111549A1 |
Other References:
CHAKRABORTI,BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2003年 1月 1日,V13 N8,P1403-1408
Attorney, Agent or Firm:
Koichi Tsujii
Sadao Kumakura
Nobuo Ogawa
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Sadao Kumakura
Nobuo Ogawa
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki